BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6994944)

  • 1. Hypercalcaemia in malignancy.
    Bockman RS
    Clin Endocrinol Metab; 1980 Jul; 9(2):317-33. PubMed ID: 6994944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.
    Ralston SH; Fogelman I; Gardiner MD; Boyle IT
    Br Med J (Clin Res Ed); 1984 May; 288(6428):1405-8. PubMed ID: 6426577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The significance of early diagnosis of cancer-related hypercalcaemia].
    Radványi I; Csikós A; Balogh S
    Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypercalcemia in blood diseases and cancers].
    Fouqueray B; Pruna A; Idatte JM
    Rev Prat; 1989 Apr; 39(11):937-41. PubMed ID: 2717865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and management of cancer associated hypercalcaemia.
    Ralston SH
    Cancer Surv; 1994; 21():179-96. PubMed ID: 8564993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone.
    Clines GA; Guise TA
    Endocr Relat Cancer; 2005 Sep; 12(3):549-83. PubMed ID: 16172192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcaemia of malignancy.
    Kelly PJ; Eisman JA
    Cancer Metastasis Rev; 1989 Jun; 8(1):23-52. PubMed ID: 2667784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignancy-associated hypercalcaemia: resolution of controversies over vitamin D metabolism by a pathophysiological approach to the syndrome.
    Schweitzer DH; Hamdy NA; Frölich M; Zwinderman AH; Papapoulos SE
    Clin Endocrinol (Oxf); 1994 Aug; 41(2):251-6. PubMed ID: 7923831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of hypercalcaemia of malignancy.
    Mundy GR
    Clin Endocrinol (Oxf); 1985 Dec; 23(6):705-14. PubMed ID: 3006948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
    Plosker GL; Goa KL
    Drugs; 1994 Jun; 47(6):945-82. PubMed ID: 7521833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercalcaemia and hypocalcaemia: finding the balance.
    Body JJ; Niepel D; Tonini G
    Support Care Cancer; 2017 May; 25(5):1639-1649. PubMed ID: 28078478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancy-associated hypercalcaemia: relationship between mechanisms of hypercalcaemia and response to antihypercalcaemic therapy.
    Ralston SH; Gardner MD; Jenkins AS; McKillop JH; Boyle IT
    Bone Miner; 1987 May; 2(3):227-42. PubMed ID: 2974309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathogenesis of humoral hypercalcaemia of malignancy.
    Ralston SH
    Lancet; 1987 Dec; 2(8573):1443-6. PubMed ID: 2892002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of osteolytic bone destruction.
    Mundy GR
    Bone; 1991; 12 Suppl 1():S1-6. PubMed ID: 1954046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms of human tumour-induced osteolysis and hypercalcaemia.
    Dowsett M
    Invest Cell Pathol; 1978; 1(2):159-70. PubMed ID: 401332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the hypercalcaemia of malignancy by peritoneal dialysis.
    Miach PJ; Dawborn JK; Martin TJ; Moon WJ
    Med J Aust; 1975 Jun; 1(25):782-4. PubMed ID: 1152762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypercalcaemia: historical perspectives and present management.
    Tattersall MH
    Support Care Cancer; 1993 Jan; 1(1):19-25. PubMed ID: 8143097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypercalcemia of malignancy--new insights into an old syndrome.
    Esbrit P
    Clin Lab; 2001; 47(1-2):67-71. PubMed ID: 11214225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteolytic bone metastases in breast carcinoma pathogenesis, morbidity and bisphosphonate treatment.
    Elte JW; Bijvoet OL; Cleton FJ; van Oosterom AT; Sleeboom HP
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):493-500. PubMed ID: 2942409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.